Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials
Options
BORIS DOI
Publisher DOI
PubMed ID
22447805
Description
The efficacy of durable polymer drug-eluting stents (DES) is delivered at the expense of delayed healing of the stented vessel. Biodegradable polymer DES aim to avoid this shortcoming and may potentially improve long-term clinical outcomes, with benefit expected to accrue over time. We sought to compare long-term outcomes in patients treated with biodegradable polymer DES vs. durable polymer sirolimus-eluting stents (SES).
Date of Publication
2012
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Byrne, Robert A | |
Serruys, Patrick W | |
de Waha, Antoinette | |
Massberg, Steffen | |
Schömig, Albert | |
Kastrati, Adnan |
Additional Credits
Series
European Heart Journal
Publisher
Oxford University Press
ISSN
0195-668X
Access(Rights)
open.access